Modeling Active Immunotherapy Strategies Targeting Human Endogenous Retroviruses (HERVs)
Time: 2:30 pm
day: Conference Day Two
Details:
- Exploring mechanisms to break immune tolerance against HERV antigens for effective therapeutic targeting
- Developing and evaluating active immunotherapy approaches using innovative mouse models for HERV-associated diseases
